SEC Contract Filing

Filing Date: 2024-03-29

Document Content:
<DOCUMENT>
<TYPE>EX-10.66
<SEQUENCE>7
<FILENAME>nrxp-20231231xex10d66.htm
<DESCRIPTION>EX-10.66
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge 10.5.122.0--><!--Created on: 3/29/2024 08:53:32 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">Exhibit 10.66</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:12pt;font-weight:bold;">SECURITIES PURCHASE AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">This SECURITIES PURCHASE AGREEMENT (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agreement</u><font style="font-size:12pt;">&#8221;), dated as of February 29, 2024, between NRX Pharmaceuticals, Inc., a Delaware corporation (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u><font style="font-size:12pt;">&#8221;), and the investor identified on the signature pages hereto (each, including its successors and assigns, an &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Investor</u><font style="font-size:12pt;">&#8221;). Subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Act</u><font style="font-size:12pt;">&#8221;), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Investor, and each Investor, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">THE PARTIES HEREBY AGREE AS FOLLOWS:</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:72pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">1.</font></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Purchase and Sale of the Securities</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:108pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">1.1</font><font style="display:inline-block;width:21pt;"></font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Sale and Issuance of the Securities</u><font style="font-size:12pt;">.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:144pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">(a)</font><font style="display:inline-block;width:22.68pt;"></font><font style="font-size:12pt;">Prior to the Closing (as defined below), the Company shall have authorized (i) the sale and issuance to the Investor of the shares (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Shares</u><font style="font-size:12pt;">&#8221;) of its &#160;Common Stock, , par value $0.001 per share (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Common Stock</u><font style="font-size:12pt;">&#8221;), to be issued upon closing, and (iii) the sale and issuance to the Investor of the Warrants (as defined herein). The Shares and the Warrants are collectively referred to herein as the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Securities</u><font style="font-size:12pt;">&#8221;.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:144pt;margin:0pt 0pt 12pt 0pt;"><font style="font-size:12pt;">(b)</font><font style="display:inline-block;width:22.01pt;"></font><font style="font-size:12pt;">Subject to the terms and conditions of this Agreement, the Investor agrees to purchase at the Closing, and the Company agrees to sell and issue to the Investor at the Closing (i) the number of Shares set forth on the signature page hereto, and (ii) Common Stock purchase warrants (the &#8220;</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Warrants</u><font style="font-size:12pt;">&#8221;) in the form attached as </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibit B</u><font style="font-size:12pt;"> hereto, to purchase up to a number of shares of Common Stock equal to 100% such Investor&#8217;s Shares, at an exercise price of $0.38 per share of Common Stock, subject to adjustments therein, at a combined purchase price of $0.38 per Share and the accompanying Warrant.</font></p><p style="font-family:'Times New